Status:
RECRUITING
Effect of iTBS on Children With ADHD
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Conditions:
ADHD
rTMS
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Attention Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder characterized by persistent symptoms of attention deficit and/or hyperactivity/impulsivity . Currently, the firs...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ADHD in accordance with DSM-V;
- Age 6-12 years old, regardless of gender
- Right-handed
- Han nationality or born in the Han nationality Ghetto
- The course of the disease is greater than 6 months
- Webster children's intelligence ≥ 70
- The patient's guardian agrees and signs an informed consent form.
Exclusion
- Concomitant mental disorders such as anxiety and depression;
- Widespread developmental disorders and other neurological developmental related disorders;
- Complication with other important organ diseases such as heart and lungs;
- Suffering from diseases such as epilepsy and tic disorder;
- Individuals who cannot tolerate rTMS treatment or cannot cooperate with treatment.
- Patients taking psychoactive drugs, antipsychotics, antidepressants, or mood stabilizers 3 months prior to enrollment or during rTMS treatment; In addition to the minimum effective therapeutic dose of Tomoxetine (1.2-1.4 mg • kg/day), there has been systematic use of first-line ADHD drugs in clinical practice Webster's intelligence\<70
- Implantation of metal and electronic components in the body (excluding the oral cavity), such as pacemakers;
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06010966
Start Date
September 1 2023
End Date
July 31 2026
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China, 310000